ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
내분비 검사 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.7%로 38억 9,000만 달러로 성장할 것입니다. 예측 기간의 성장은 내분비 질환의 유병률 증가, 국방비 증가, 고령화, 인지도 향상 및 조기 진단, 인식의 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 바이오마커 검출의 발전, 오믹스 기술의 통합, 인공지능과 머신러닝, 품질 보증 및 표준화, 공동 연구 및 중개 의료 등이 있습니다.
향후 5년간 8.7%의 성장률 전망은 지난번 전망치보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스위스나 네덜란드에서 개발된 면역분석 분석기 및 시약의 가격을 급등시켜 대사 이상 검출을 지연시키고 진단 실험실의 비용을 상승시킴으로써 미국의 첨단 내분비 검사의 채택을 방해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
당뇨병 유병률의 증가는 내분비 검사 시장의 성장을 촉진할 것으로 예상됩니다. 당뇨병은 고혈당(포도당) 수치를 특징으로 하는 질환군으로 식습관, 좌식생활, 유전적 요인, 고령화 등의 요인으로 인해 유병률이 증가하고 있습니다. 헤모글로빈 A1c, 공복 혈당, C 펩타이드 등의 검사를 포함한 내분비 검사는 당뇨병 진단, 포도당 수치 모니터링, 인슐린 생산 및 감수성 평가에 필수적입니다. 예를 들어, 2024년 6월 국민보건서비스(NHS)는 40세 미만 당뇨병 환자가 크게 증가하여 2022년 17만 3,166명에서 2023년 21만 6,440명으로 늘어났다고 보고했습니다. 이러한 급격한 증가는 젊은 층의 당뇨병 유병률에 대한 우려스러운 추세를 보여주고 있습니다. 그 결과, 당뇨병 유병률의 증가는 내분비 검사 솔루션에 대한 수요를 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 내분비 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 내분비 검사 시장 : 성장률 분석
세계의 내분비 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 내분비 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 내분비 검사 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 내분비 검사 시장 테스트 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
에스트라디올(E2) 검사
난포자극호르몬(FSH) 검사
인간 융모성 성선자극호르몬(hCG) 호르몬 검사
황체 형성 호르몬(LH) 검사
디하이드로에피안드로스테론 황산염(DHEAS) 검사
프로게스테론 검사
테스토스테론 검사
갑상선 자극 호르몬(TSH) 검사
프로락틴 검사
기타 유형
세계의 내분비 검사 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
텐덤 질량분석법
면역측정
단클론항체 및 다클론항체 기술
센서 기술
임상화학
기타 기술
세계의 내분비 검사 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
임상 검사실
진단 센터
기타 최종사용자
세계의 내분비 검사 시장 : 하위 세분화 에스트라디올(E2) 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
혈청 에스트라디올 검사
요중 에스트라디올 검사
세계의 내분비 검사 시장 : 하위 세분화 난포자극호르몬(FSH) 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
FSH 혈청 검사
FSH 소변 검사
세계의 내분비 검사 시장 : 하위 세분화 인간 융모성 성선자극호르몬(hCG) 호르몬 검사(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
정량 hCG 검사
정성 hCG 검사
세계의 내분비 검사 시장 : 하위 세분화 황체 형성 호르몬(LH) 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
LH혈청 검사
LH 소변 검사
세계의 내분비 검사 시장 : 하위 세분화 디하이드로에피안드로스테론 황산염(DHEAS) 검사, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
혈청 DHEAS 검사
타액 DHEAS 검사
세계의 내분비 검사 시장 : 하위 세분화 프로게스테론 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
혈청 프로게스테론 검사
요중 프로게스테론 검사
세계의 내분비 검사 시장 : 하위 세분화 테스토스테론 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
무료 테스토스테론 검사
총테스토스테론 검사
세계의 내분비 검사 시장 : 하위 세분화 갑상선 자극 호르몬(TSH) 검사(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
TSH 혈청 검사
TSH 타액 검사
세계의 내분비 검사 시장 : 하위 세분화 프로락틴 검사(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
혈청 프로락틴 검사
혈장 프로락틴 검사
세계의 내분비 검사 시장 : 하위 세분화 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
코르티솔 검사
인슐린 검사
성장호르몬(GH) 검사
알도스테론 검사
제7장 지역별·국가별 분석
세계의 내분비 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 내분비 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
내분비 검사 시장 : 경쟁 구도
내분비 검사 시장 : 기업 개요
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Roche Holding Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Agilent Technologies Inc.
PerkinElmer Inc.
BioMerieux SA
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
SD Biosensor Inc.
Qiagen N.V.
Ortho Clinical Diagnostics
Kronus Inc.
Randox Laboratories Ltd.
Fujirebio Diagnostics Inc.
Inova Diagnostics Inc.
Sekisui Diagnostics LLC
Mercodia AB
ZEUS Scientific Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
내분비 검사 시장 2029 : 새로운 기회를 제공하는 국가
내분비 검사 시장 2029 : 새로운 기회를 제공하는 부문
내분비 검사 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.
The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.
The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $3.89 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.
The forecast of 8.7% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced endocrine testing by inflating prices of immunoassay analyzers and reagents developed in Switzerland and the Netherlands, resulting in slower metabolic disorder detection and higher diagnostic lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of diabetes is expected to drive the growth of the endocrine testing market. Diabetes is a group of diseases characterized by high blood sugar (glucose) levels, and its prevalence is rising due to factors such as poor dietary habits, sedentary lifestyles, genetic factors, and an aging population. Endocrine testing, including tests like hemoglobin A1c, fasting plasma glucose, and C-peptide, is essential in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS) reported a significant increase in diabetes cases among individuals under 40, with the number rising from 173,166 in 2022 to 216,440 in 2023. This surge indicates a concerning trend in diabetes prevalence among younger populations. As a result, the growing prevalence of diabetes is fueling the demand for endocrine testing solutions.
Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.
In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.
North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endocrine Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for endocrine testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endocrine testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Endocrine Testing Market Characteristics
3. Endocrine Testing Market Trends And Strategies
4. Endocrine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Endocrine Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Endocrine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Endocrine Testing Market Growth Rate Analysis
5.4. Global Endocrine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Endocrine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Endocrine Testing Total Addressable Market (TAM)
6. Endocrine Testing Market Segmentation
6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Hormone Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Other Types
6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tandem Mass Spectrometry
Immunoassay
Monoclonal And Polyclonal Antibody Technologies
Sensor Technology
Clinical Chemistry
Other Technologies
6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinical Laboratories
Diagnostic Centers
Other End-Users
6.4. Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Estradiol Test
Urinary Estradiol Test
6.5. Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
FSH Serum Test
FSH Urine Test
6.6. Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Quantitative hCG Test
Qualitative hCG Test
6.7. Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
LH Serum Test
LH Urine Test
6.8. Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum DHEAS Test
Saliva DHEAS Test
6.9. Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Progesterone Test
Urinary Progesterone Test
6.10. Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Free Testosterone Test
Total Testosterone Test
6.11. Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
TSH Serum Test
TSH Saliva Test
6.12. Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Prolactin Test
Plasma Prolactin Test
6.13. Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cortisol Test
Insulin Test
Growth Hormone (GH) Test
Aldosterone Test
7. Endocrine Testing Market Regional And Country Analysis
7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
